Tag
Tag: GenSight Biologics
Sofinnova Partners Raises €333M for its Newest Life Sciences-Focused Fund
It’s News Roundup Time! CRISPR, Cancer Diagnostics, and More …
Can Gene Therapy Become The Cure For Blindness?
After Unexpected Setback, GenSight Seeks Approval for Blindness Gene Therapy
Placebo Beats a Gene Therapy for Blindness in a Phase 3 Trial
This Gene Therapy for Vision Loss is Safe and Effective After Two Years
French Biotech Starts Trials to Restore Sight in All Types of Retinitis Pigmentosa
Happy 2018, Here Are the Top 9 European Biotech Companies To Watch
Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017
Update: French Gene Therapy Yields Longer Term Sight Restoration, Eyes Phase III
